Skip to content
In deliveryUnited KingdomServices

Nucleic Acid Testing (NAT) Managed Service

Published
Published 23 October 2024
Deadline
Closed 29 November 2024

Overview

The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and Welsh Blood Service all require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authority’s information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.

Key details

Country
United Kingdom
Status
In delivery
Category
Services
Procedure
Open
Published
23 October 2024
Deadline
Closed
Classification (CPV)
Repair and maintenance services of medical equipment

Award outcome

Awarded value
£7,300,000
Award date
16 October 2025
Contract period
— → 9 September 2032
Winner
  • Roche Diagnostics Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    20 October 2025

    View notice ↗
  2. Contract Notice

    23 October 2024

    View notice ↗

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Nucleic Acid Testing (NAT) Managed Service — won by Roche Diagnostics Ltd — Skim